Skip To Main Content
Adeyinka Adejumo on Muck Rack

Adeyinka Adejumo

As seen in: The Journal of Immunology, International Journal of Cardiology, Gastrointestinal Endoscopy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Adeyinka

Contact Adeyinka, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

THE ADDITION OF GLP-1 RECEPTOR AGONIST THERAPY 12 MONTHS AFTER ENDOSCOPIC SLEEVE GASTROPLASTY ENHANCES THREE-YEAR WEIGHT LOSS OUTCOMES

|
By Ali Lahooti, Chino Aneke-Nash, Muhammad U. Baig, Kate Johnson, Adeyinka Adejumo, Sean Rangwani, Zane Gouda, Ana Hamann, Mark Hanscom, Andrea Herr, Adam Buckholz, Carolyn Newberry, Kartik Sampath, David Carr-Locke, SriHari Mahadev, Sonal Kum
| Gastrointestinal Endoscopy Verified
Proportion of patients achieving >10% total body weight loss (TBWL) at 36 months across treatment groups. Error bars represent standard errors.
Open in Who Shared View Duplicates (2) Issue with article?

Incidence and outcomes of cardiac tamponade in patients undergoing cardiac resynchronization therapy

|
By Adeyinka Adejumo, Emmanuel Akintoye, Oluwole Adegbala, Olakanmi Olagoke
| International Journal of Cardiology Verified
Publication HistoryPublished online: July 19, 2018Accepted: July 17, 2018; Received in revised form: July 4, 2018; Received: May 17, 2018;
Open in Who Shared Issue with article?

Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study

|
By Adeyinka Adejumo, Biomedical Engineering, Samson Alliu, Tokunbo Opeyemi Ajayi
| PLOS
Cannabis use is associated with reduced prevalence of obesity and diabetes mellitus (DM) in humans and mouse disease models. Obesity and DM are a well-established independent risk factor for non-alcoholic fatty liver disease (NAFLD), the most prevalent liver disease globally. The effects of cannabis use on NAFLD prevalence in humans remains ill-defined. Our objective is to determine the relationship between cannabis use and the prevalence of NAFLD in humans.
Open in Who Shared Issue with article?
See all 5 articles